Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ligand Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
LGND
Nasdaq
8731
https://www.ligand.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ligand Pharmaceuticals Inc
Ligand (LGND) Down 15.5% Since Last Earnings Report: Can It Rebound?
- Mar 28th, 2024 3:30 pm
Ligand Pharmaceuticals (LGND) Falls More Steeply Than Broader Market: What Investors Need to Know
- Mar 26th, 2024 10:15 pm
Here is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) is a Trending Stock
- Mar 21st, 2024 1:00 pm
Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to Consider
- Mar 20th, 2024 10:00 pm
Ligand (LGND) Is Considered a Good Investment by Brokers: Is That True?
- Mar 19th, 2024 1:30 pm
Ligand Pharmaceuticals (LGND) Declines More Than Market: Some Information for Investors
- Mar 14th, 2024 10:00 pm
Ligand Pharmaceuticals (LGND) Gains As Market Dips: What You Should Know
- Mar 8th, 2024 11:00 pm
Is Trending Stock Ligand Pharmaceuticals Incorporated (LGND) a Buy Now?
- Mar 7th, 2024 2:00 pm
Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference
- Mar 5th, 2024 9:01 pm
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mar 4th, 2024 1:00 pm
Wall Street Analysts See Ligand (LGND) as a Buy: Should You Invest?
- Feb 29th, 2024 2:30 pm
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 2:38 pm
Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges
- Feb 28th, 2024 12:34 pm
Ligand Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
- Feb 28th, 2024 10:59 am
Q4 2023 Ligand Pharmaceuticals Inc Earnings Call
- Feb 28th, 2024 3:15 am
Ligand Pharmaceuticals Inc (LGND) Reports Solid Earnings Amidst Operational Transformation
- Feb 27th, 2024 12:52 pm
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
- Feb 27th, 2024 12:00 pm
Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®
- Feb 22nd, 2024 9:01 pm
Why Ligand Pharmaceuticals (LGND) Dipped More Than Broader Market Today
- Feb 20th, 2024 11:00 pm
Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
- Feb 16th, 2024 1:00 pm
Scroll